Major points in pharma times Oct 19
1.Stephan and James Huang to develop vaccines for cancer. It works by mRNA encoding for protein that neutralize cancer cells.
2. Lonsurf(triflurodine) to treat gastric cancer. ROCHE's Tensertiq(atezolizumab) to treat metastatic lung cancer.
3.Novartis's Ofatumumam more effective than Sanofi's Aufagio to treat multiple sclerosis.
4UK uses biosimilar medicines , saves £200
5.Statins to be prescribed by pharmacist .
Main points in pharmacy times: Oct19
Drug therapy of choice to treat inflammation
-biological DMARDS (tissue necrotic factor blocker)::subcutaneous olimumab
-convention DMARDS :methotrexate
-Tcell costimulation modulator
-Non biological DMARDs
*Disease-modifying antirheumatic drugs (DMARDs) are a group of medications commonly used in people with rheumatoid arthritis. Some of these drugs are also used in treating other conditions such as ankylosing spondylitis, psoriatic arthritis, and systemic lupus erythematosus.
Comments
Post a Comment